Alexander Grunenberg

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

University Hospital Ulm(Current)

Universität Ulm

Centre Hospitalier de Lens

Institut Paoli-Calmettes

Complejo Hospitalario de Salamanca

Alexander Grunenberg is an author at University Hospital Ulm specializing in bortezomib-based therapy, medicine, and chemotherapy in hematologic malignancies.

ORCID

Publications per year

2020–2024

Publications

Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia

Christian Buske, Meletios Α. Dimopoulos, Alexander Grunenberg et al. · Journal of Clinical Oncology · 2023 · 41 citations

Medicine, Oncology, Pharmacology +14

Bortezomib in Combination with Dexamethasone, Rituximab and Cyclophosphamide (B-DRC) As First - Line Treatment of Waldenstrom's Macroglobulinemia: Results of a Prospectively Randomized Multicenter European Phase II Trial

Christian Buske, Meletios Α. Dimopoulos, Alexander Grunenberg et al. · Blood · 2020 · 16 citations

Medicine, Hematology, Pharmacotherapy +10

How to manage waldenström’s macroglobulinemia in 2024

Alexander Grunenberg, Christian Buske · Cancer Treatment Reviews · 2024 · 16 citations

Health Professions, Hematology, Immunotherapy +1

Tafasitamab and Lenalidomide in Relapsed/Refractory B-Cell Lymphoma: A Multicenter Retrospective Real-World-Study of Patients from Germany and Austria

Anna Ruckdeschel, Koemm Sabrina, Max S. Topp et al. · Blood · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

1–4 of 4